Abstract
Fibrous dysplasia is a benign deforming lesion involving one or several bones in which the structure of bone is replaced with altered osteofibrous tissue. It appears in a mono or polyostotic form. Treatment is based on biphosphonates and also by surgery when deformed bones occur.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
Fibrous dysplasia produced bone lesions with altered structure of the bone as a tissue and organ in which the bone is replaced with fibrocystic zones. The bone is transformed becoming wider and with thin corticals. The bone becomes deformed and fragile [1,2,3]. Fractures in the proximal femur and the Shepherd’s crook deformity are characteristics (Fig. 20.1).
The etiology is unknown, but associated chromosomal abnormalities have been found, probably a mutation in the gen GS alpha in the human chromosome 20q13. It is not a inherited disease. The high production of FGF-23 can lead to hypophosphatemia.
It can compromise one bone, as in the monostotic form, or many bones, as in the poliostotic form. The skull, jaw, ribs, pelvis, femur and tibia are mainly involved. In the poliostotic form there is a trend of the lesions to be placed towards one half of the body. The monostotic form makes up about 80% of the cases.
Early puberty (mostly in women), skin spots, coffee and milk markings as in the coast of Maine pattern, and poliostotic fibrous dysplasia constitutes the Albright syndrome or McCune–Albright syndrome (20% of cases of fibrous dysplasia).
The combination of poliostotic fibrous dysplasia and soft-tissue intramuscular myxomas is named the Mazabraud syndrome.
The age of diagnosis is between the first and third decades of life. Although the genetic lesion is present at birth, most times it remains asymptomatic until adolescence.
Clinical Symptoms
For many years patients can be asymtomatic or have a casual finding. The progression of the lesions can frequently produce swelling and deformation of the segment, without any pain or few pain except when a pathological fracture is produced.
Deformations of the lower extremities are very notorious with bowing of the thigh and or leg produced by the plastic deformity of the femur and tibia which curve the bones induced for the body weight.
Craniofacial bone affections produce deformation of the skull cap or facial asymetry and neurological symptoms of the cranial nerves produced by obstruction of the cranial hollows in the base of the skull.
The progression of the lesions sometimes halts with the end of skeletal growth. That is an important consideration for the treatment.
Malignant transformation can occasionally occurs [4].
Rx Imaging
The radiological aspect is characteristic, with zones of cysts with different sizes rounded with areas of fibrous dense bone. Sometimes the image resembles “frosted glass”. The bones frequently compromised are femur, tibia, ribs, maxilla and craniofacial bones (Figs. 20.2 and 20.3).
The cranial bones show very calcified zones, which explains the closing of the hollows of the cranial nerves in the skull base.
Scintigraphy (with Tc99)
It is very useful to detect the distribution of the affected bones showing an hypercaptation of the radioisotope. Also it can be useful to measure the diminution of the activity of the lesion.
Magnetic Resonance
The signal is low in T1 but high in T2 in the affected bones.
Histology
The normal bone is changed into new bone with deformed bone trabeculaes, fibrous tissue with fibroblastos, osteoid tissue and giant cells replacing the normal bone marrow. There is fibroblast proliferation surrounding islands of woven bone. The truncated dysplastic trabeculaes are named as the “soup of Chinese alphabet.” Another typical finding is the lack of osteoblasts around the bone trabeculaes.
Diferential Diagnosis
When there is an image of cartilage enchondroma can be proposed and if it is poliostotic, Ollier disease can be proposed. Poliostotic lesions can be proposed with neurofibromatosis but in these cases the typical intramedular bone findings of fibrous dysplasia are not present. A solitary cyst can be also be proposed.
If there is a lonely tibia lesion the diferential diagnosis will be with osteofibrous dysplasia or adamantinoma [12].
Treatment
A biopsy is useful to define the diagnosis.
Observation is indicated in asymptomatic pre-adolescent patients. In painful, big monostotic lesions intramedular fixation is indicated [8] Curretage alone has a high incidence of relapse, so must be combined with a structural cortical bone graft (fibula) or cancellous allograft and endomedular synthes according to the case. Autogenous bone graft is not useful because it quickly turns into fibrous dysplastic bone.
Coxa vara deformity is an indication for intertrocanteric osteotomy [6].
In adults with deformity and extensive proximal femur lesions a hip endoprosthesis can be indicated (Figs. 20.4 and 20.5).
The medical treatment with pamidronate disodium [5, 7, 9,10,11] can be useful in painful cases. Doses: 0,5 to 1,5 by each kg of weight of the patient Iiv in three days repeated every three or four months.
There is no indication for radiotherapy. There is a risk of long term secondary malignant lesions.
References
Pitcher JD, Weber KL. Benign fibrous and histiocytic lesions. In: Schwartz HS, editor. Orthopedic knowledge update musculoskeletal tumors. 2nd ed. Rosemont, IL: American Academy of Orthopedic Surgeons; 2007. p. 121–32.
Fibrous dysplasia. In: Campanacci M, Bertoni F, Bacchini P, Enneking W, Notini S, editors. Bone and soft tissue tumors. New York: Springer-Verlag;1990. p. 391–418.
Hillock R, Zuppan C. Fibrous dysplasia. Orthop Knowl. 2007; 5(4).
Ruggieri P, Sim FH, Bond JR, Unni KK. Malignancies in fibrous dysplasia. Cancer. 1994;73(5):1411–24.
Chapurlat RD, Hugueny P, Delmas PD, Meunier PJ. Treatment of fibrous dysplasia of bone with intravenous pamidronate: Long-term effectiveness and evaluation of predictors of response to treatment. Bone. 2004;35(1):235–42.
Guille JT, Kumar SJ, MacEwen GD. Fibrous dysplasia of the proximal part of the femur: Long-term results of curettage and bone-grafting and mechanical realignment. J Bone Joint Surg Am. 1998;80(5):648–58.
Lane JM, Khan SN, O’Connor WJ, et al. Bisphosphonate therapy in fibrous dysplasia. Clin Orthop Relat Res. 2001;382:6–12.
Ozaki T, Hamada M, Sugihara S, Kunisada T, Mitani S, Inoue H. Treatment outcome of osteofibrous dysplasia. J Pediatr Orthop B. 1998;7(3):199–202.
Boyce AM, Chong WH, Yao J, et al. Denosumab treatment for fibrous dysplasia. J Bone Miner Res. 2012;27(7):1462–70.
DiMeglio LA. Bisphosphonate therapy for fibrous dysplasia. Pediatr Endocrinol Rev. 2007;4(Suppl 4):440–5.
Mansoori LS, Catel CP, Rothman MS. Bisphosphonate treatment in polyostotic fibrous dysplasia of the cranium: Case report and literature review. Endocr Pract. 2010;16(5):851–4.
Most MJ, Sim FH, Inwards CY. Osteofibrous dysplasia and adamantinoma. J Am Acad Orthop Surg. 2010; 18(6):358–366.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer-Verlag London Ltd., part of Springer Nature
About this chapter
Cite this chapter
Paulos, J. (2021). Fibrous Dysplasia. In: Paulos, J., Poitout, D.G. (eds) Bone Tumors. Springer, London. https://doi.org/10.1007/978-1-4471-7501-8_20
Download citation
DOI: https://doi.org/10.1007/978-1-4471-7501-8_20
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-7499-8
Online ISBN: 978-1-4471-7501-8
eBook Packages: MedicineMedicine (R0)